MYGN weakness - perhaps also cause management did not reiterate its prior guidance and said demand for BRACAnalysis tend to slow in Q3 due to insurance re-sets.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.